D.A. Davidson & Co’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5,940
| Closed | -$247K | – | 1348 |
|
|
2023
Q2 | $247K | Sell |
5,940
-2,063
| -26% | -$85.6K | ﹤0.01% | 1171 |
|
|
2023
Q1 | $481K | Sell |
8,003
-2,004
| -20% | -$121K | 0.01% | 906 |
|
|
2022
Q4 | $734K | Sell |
10,007
-72
| -0.7% | -$5.28K | 0.01% | 726 |
|
|
2022
Q3 | $766K | Buy |
10,079
+941
| +10% | +$71.5K | 0.01% | 678 |
|
|
2022
Q2 | $635K | Sell |
9,138
-228
| -2% | -$15.8K | 0.01% | 745 |
|
|
2022
Q1 | $776K | Buy |
9,366
+3,440
| +58% | +$285K | 0.01% | 726 |
|
|
2021
Q4 | $445K | Sell |
5,926
-1,635
| -22% | -$123K | ﹤0.01% | 915 |
|
|
2021
Q3 | $878K | Buy |
7,561
+2,501
| +49% | +$290K | 0.01% | 669 |
|
|
2021
Q2 | $1.12M | Buy |
5,060
+1,436
| +40% | +$318K | 0.01% | 595 |
|
|
2021
Q1 | $479K | Sell |
3,624
-1,607
| -31% | -$212K | 0.01% | 820 |
|
|
2020
Q4 | $905K | Buy |
+5,231
| New | +$905K | 0.01% | 527 |
|
|
2019
Q2 | – | Sell |
-8,342
| Closed | -$402K | – | 1106 |
|
|
2019
Q1 | $402K | Buy |
8,342
+1,260
| +18% | +$60.7K | 0.01% | 750 |
|
|
2018
Q4 | $237K | Buy |
7,082
+478
| +7% | +$16K | ﹤0.01% | 906 |
|
|
2018
Q3 | $346K | Sell |
6,604
-90
| -1% | -$4.72K | 0.01% | 852 |
|
|
2018
Q2 | $210K | Buy |
+6,694
| New | +$210K | ﹤0.01% | 1025 |
|